反応式
C([O:5][C:6]([NH:8][C@H:9]([CH:33]1[CH2:38][CH2:37][CH2:36][CH2:35][CH2:34]1)[C:10]([N:12]1[CH2:16][CH2:15][CH2:14][C@H:13]1[C:17]([NH:19][CH2:20][C:21]1[CH:31]=[C:30]([Cl:32])[CH:29]=[CH:28][C:22]=1[O:23][CH2:24][C:25]([OH:27])=O)=[O:18])=[O:11])=O)(C)(C)C.Cl.C(OC(=O)[CH2:46][NH2:47])(C)(C)C.C(N(CC)CC)C.C1C=NC2N(O)N=NC=2C=1.C(Cl)CCl>CN(C=O)C.CCOC(C)=O>[Cl:32][C:30]1[CH:29]=[CH:28][C:22]2[O:23][CH2:24][C:25](=[O:27])[NH:47][CH2:46][C:6](=[O:5])[NH:8][C@H:9]([CH:33]3[CH2:38][CH2:37][CH2:36][CH2:35][CH2:34]3)[C:10](=[O:11])[N:12]3[CH2:16][CH2:15][CH2:14][C@H:13]3[C:17](=[O:18])[NH:19][CH2:20][C:21]=2[CH:31]=1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 2
反応条件
- 温度
- 0 °C
実験手順
To a solution of 0.049 g (0.09 mmol) [2-({[((2S)-1-{(2R)-2-[(tert-butoxycarbonyl) amino]-2-cyclohexylethanoyl} pyrrolidin-2-yl)carbonyl]amino} methyl)-4-chlorophenoxy]acetic acid (J. Med. Chem 1998, 41, 3210) in 3 mL DMF was added 0.018 g (0.1 mmol) glycine tertbutyl ester hydrochloride, 0.015 mL (0.1 mmol) triethylamine, 0.014 g (0.1 mmol) HOAt and 0.029 g (0.15 mmol) EDC. After 3 hours the reaction mixture was diluted with 100 mL EtOAc, washed with 50 mL each of 10% aqueous KHSO4, dilute brine, and brine, then dried over Na2SO4, filtered, and concentrated. The residue was dissolved in 3 mL CH2Cl2 and cooled to 0° C. whereupon 1.5 mL trifluoroacetic acid was added and the mixture stirred 30 minutes at 0° C. then warmed to room temperature for 2 hours. To this was added 50 mL toluene and the mixture concentrated, redissolved in CH2Cl2 and toluene and concentrated. The residue was dissolved in 50 mL DMF and to this was added 0.03 mL (0.2 mmol) triethylamine, 0.015 g (0.1 mmol) HOAt and 0.030 g (0.15 mmol) EDC. After 64 hours the reaction mixture was concentrated and the residue diluted with 50 mL EtOAc, washed with 20 mL each of 10% aqueous KHSO4, dilute brine, and brine, then dried over Na2SO4, filtered, and concentrated. Purification by flash chromatography (1.5×12 cm silica gel, linear gradient 1–9% MeOH/CH2Cl2 afforded (6R,20aS)-16-chloro-6-cyclohexyl-2,3,6,7,9,10,18,19-octahydro-1H-pyrrolo[1,2-j][1,4,7,10,13] benzoxatetraazacyclohexadecine-5,8,11,20 (12H,20aH)-tetrone as a white flaky solid. 1H NMR (CD3OD, 400 MHz): δ 7.32 (d, J=2.65 Hz, 1H), 7.24 (dd, J=2.65 and 8.8 Hz, 1H), 7.01 (d, J=8.8 Hz, 1H), 4.75 (d, J=14.0 Hz, 1H), 4.69 (d, J=14.3 Hz, 1H), 4.60 (d, J=14.3 Hz, 1H); 4.45 (dd, J=3.2 and 8.5 Hz, 1H), 4.3 (d, J=9.97 Hz, 1H), 4.15 (d, J=15.6 Hz, 1H), 4.13 (d, J=14.0 Hz, 1H), 3.97 (m, 1H), 3.73 (d, J=15.6 Hz, 1H), 3.61 (m, 1H), 2.16 (m, 1H), 2.08 (m, 1H), 2.0–1.88 (m, 3H), 1.8–1.6 (m, 5H), 1.58 (m, 1H), 1.28 (m, 2H), 1.04 (m, 1H); exact mass calculated for C24H31C1N4O5: 491.2056 found 491.2067. Analytical HPLC (Zorbax SB-C18 4.6×75 mm, 5% to 95% CH3CN in 0.1% aqueous H3PO4):>99% at 215 nm.
後処理
- washwashed with 50 mL each of 10% aqueous KHSO4, dilute brine, and brine
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated
- dissolutionThe residue was dissolved in 3 mL CH2Cl2
- additionwas added
- temperaturethen warmed to room temperature for 2 hours
- additionTo this was added 50 mL toluene
- concentrationthe mixture concentrated
- dissolutionredissolved in CH2Cl2
- concentrationtoluene and concentrated
- dissolutionThe residue was dissolved in 50 mL DMF
- concentrationAfter 64 hours the reaction mixture was concentrated
- additionthe residue diluted with 50 mL EtOAc
- washwashed with 20 mL each of 10% aqueous KHSO4, dilute brine, and brine
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated
- customPurification by flash chromatography (1.5×12 cm silica gel, linear gradient 1–9% MeOH/CH2Cl2
出典と根拠
- ORDレコード
- ord-a9969a0f2f7a4f47a1fe7d91077a1b28
- 出典データセット
- uspto-grants-2006_08
- 特許番号
- US07084134B2
関連ノート
読み込み中…